Literature DB >> 19675098

PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells.

Fuyuki Sato1, Chihiro Nagata, Yang Liu, Takahiro Suzuki, Jun Kondo, Satoko Morohashi, Tadaatsu Imaizumi, Yukio Kato, Hiroshi Kijima.   

Abstract

PERIOD1 (PER1) is a clock gene. We examined the effect of knockdown of PER1 on apoptosis in pancreatic cancer (MIA PaCa-2 and PANC-1) and hepatocellular carcinoma (HepG2) cells. Transfection of siRNA against PER1 into these cells increased the cleaved forms of caspases and poly-ADP-ribose-polymerase and induced apoptosis in all three cell lines. In the two pancreatic cancer cell lines, PER1 knockdown resulted in upregulation of Bax and downregulation of Bcl-2. Expression of p53 was not altered in the two pancreatic cancer cell lines containing mutated p53, but was upregulated in the HepG2 cells containing wild-type p53. Cell proliferation of MIA PaCa-2 and HepG2 was inhibited by PER1 knockdown. We also examined, by immunohistochemical staining, the expression of PER1 in pancreatic cancer tissue and found that PER1 was strongly expressed in pancreatic cancer cells. These results indicate that PER1 acts as an anti-apoptotic factor in pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675098     DOI: 10.1093/jb/mvp126

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  23 in total

1.  miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.

Authors:  Yuyan Han; Fanyin Meng; Julie Venter; Nan Wu; Ying Wan; Holly Standeford; Heather Francis; Cynthia Meininger; John Greene; Jerome P Trzeciakowski; Laurent Ehrlich; Shannon Glaser; Gianfranco Alpini
Journal:  J Hepatol       Date:  2016-02-24       Impact factor: 25.083

2.  Circadian gene expression and clinicopathologic correlates in pancreatic cancer.

Authors:  Daniel Relles; Jocelyn Sendecki; Galina Chipitsyna; Terry Hyslop; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2012-12-20       Impact factor: 3.452

3.  Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice.

Authors:  Maria Comas; Karen K Kuropatwinski; Michelle Wrobel; Ilia Toshkov; Marina P Antoch
Journal:  Chronobiol Int       Date:  2014-06-16       Impact factor: 2.877

4.  Effect of circadian clock mutations on DNA damage response in mammalian cells.

Authors:  Shobhan Gaddameedhi; Joyce T Reardon; Rui Ye; Nuri Ozturk; Aziz Sancar
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

Review 5.  Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.

Authors:  Tatsuo Kanda; Xia Jiang; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 6.  Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes.

Authors:  Elizabeth A Yu; David R Weaver
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

7.  Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma.

Authors:  Ningbo Zhao; Kai Yang; Genling Yang; Dan Chen; Hong Tang; Dan Zhao; Chunrong Zhao
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

8.  Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma.

Authors:  Rui Chen; Kai Yang; Ning-Bo Zhao; Dan Zhao; Dan Chen; Chun-Rong Zhao; Hong Tang
Journal:  Onco Targets Ther       Date:  2012-11-27       Impact factor: 4.147

9.  Pancreatic cancer gene therapy: from molecular targets to delivery systems.

Authors:  Cristina Fillat; Anabel Jose; Xavier Bofill-Deros; Ana Mato-Berciano; Maria Victoria Maliandi; Luciano Sobrevals
Journal:  Cancers (Basel)       Date:  2011-01-18       Impact factor: 6.639

10.  Circadian clock, cancer, and chemotherapy.

Authors:  Aziz Sancar; Laura A Lindsey-Boltz; Shobhan Gaddameedhi; Christopher P Selby; Rui Ye; Yi-Ying Chiou; Michael G Kemp; Jinchuan Hu; Jin Hyup Lee; Nuri Ozturk
Journal:  Biochemistry       Date:  2014-10-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.